ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) EBIT: ₺-5.37 Mil (TTM As of Mar. 2026)


IST:ICUGS ICU Girisim Sermayesi Yatirim Ortakligi AS IST:ICUGS
15 GF Score
Price ₺5.65
View Full Analysis

What is ICU Girisim Sermayesi Yatirim Ortakligi AS EBIT?

ICU Girisim Sermayesi Yatirim Ortakligi AS IST:ICUGS 15 EBIT is ₺-5.37 Mil as of Mar. 2026. GuruFocus rates IST:ICUGS with a GF Score™ of 15/100.

ICU Girisim Sermayesi Yatirim Ortakligi AS's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₺-5.37 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₺-5.37 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. ICU Girisim Sermayesi Yatirim Ortakligi AS's annualized ROC % for the quarter that ended in Mar. 2026 was -4.03%. ICU Girisim Sermayesi Yatirim Ortakligi AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -5,504.74%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. ICU Girisim Sermayesi Yatirim Ortakligi AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -0.27%.

ICU Girisim Sermayesi Yatirim Ortakligi AS  (IST:ICUGS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

ICU Girisim Sermayesi Yatirim Ortakligi AS's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-21.496 * ( 1 - 0% )/( (519.4 + 548.248)/ 2 )
=-21.496/533.824
=-4.03 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=497.055 - 24.318 - ( 16.128 - max(0, 75.516 - 28.853+16.128))
=519.4

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=525.183 - 28.85 - ( 0.197 - max(0, 81.742 - 29.827+0.197))
=548.248

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

ICU Girisim Sermayesi Yatirim Ortakligi AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-21.496/( ( (0.391 + max(-24.582, 0)) + (0.39 + max(-64.69, 0)) )/ 2 )
=-21.496/( ( 0.391 + 0.39 )/ 2 )
=-21.496/0.3905
=-5,504.74 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 1.433) - (24.318 + 0 + 1.697)
=-24.582

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 17.052) - (28.85 + 0 + 52.892)
=-64.69

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

ICU Girisim Sermayesi Yatirim Ortakligi AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-5.374/1996.748
=-0.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICU Girisim Sermayesi Yatirim Ortakligi AS EBIT Related Terms

ICU Girisim Sermayesi Yatirim Ortakligi AS EBIT Historical Data

* Premium members only.

The historical data trend for ICU Girisim Sermayesi Yatirim Ortakligi AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICU Girisim Sermayesi Yatirim Ortakligi AS EBIT Chart

ICU Girisim Sermayesi Yatirim Ortakligi AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.89 -11.03 -9.51 -65.41 -198.49

ICU Girisim Sermayesi Yatirim Ortakligi AS Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.92 -17.00 -8.60 0.00 -5.37

IST:ICUGS vs BLK, BX, KKR: EBIT Comparison

For the Asset Management subindustry, ICU Girisim Sermayesi Yatirim Ortakligi AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ICU Girisim Sermayesi Yatirim Ortakligi AS EV-to-EBIT vs Asset Management Industry

For the Asset Management industry and Financial Services sector, ICU Girisim Sermayesi Yatirim Ortakligi AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ICU Girisim Sermayesi Yatirim Ortakligi AS's EV-to-EBIT falls into.


IST:ICUGS
15GF Score
ICU Girisim Sermayesi Yatirim Ortakligi AS IST:ICUGS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ICU Girisim Sermayesi Yatirim Ortakligi AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-5.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₺-5.37 Mil mean?
ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) has a EBIT of ₺-5.37 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on ICU Girisim Sermayesi Yatirim Ortakligi AS.
Is ICU Girisim Sermayesi Yatirim Ortakligi AS's EBIT too high?
ICU Girisim Sermayesi Yatirim Ortakligi AS's current EBIT is ₺-5.37 Mil. Overall, ICU Girisim Sermayesi Yatirim Ortakligi AS has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ICU Girisim Sermayesi Yatirim Ortakligi AS's EBIT compare to BLK and BX?
ICU Girisim Sermayesi Yatirim Ortakligi AS's EBIT of ₺-5.37 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Asset Management company?
A good EBIT depends on the Asset Management industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on ICU Girisim Sermayesi Yatirim Ortakligi AS. ICU Girisim Sermayesi Yatirim Ortakligi AS's current EBIT is ₺-5.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Girisim Sermayesi Yatirim Ortakligi AS stock overvalued right now?
ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) has a current EBIT of ₺-5.37 Mil. The current EBIT is ₺-5.37 Mil. ICU Girisim Sermayesi Yatirim Ortakligi AS's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS), the current EBIT is ₺-5.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ICU Girisim Sermayesi Yatirim Ortakligi AS Business Description

Address Sair Esref Boulevard Ragip Samli Business Center, Block No. 6 Ic Kapi No. 706, Ismet Kaptan District, Izmir, Konak, TUR, 34398
ICU Girisim Sermayesi Yatirim Ortakligi AS is a Turkey based investment banking company. It operates as a venture capital company. The company invests in portfolio of companies which includes OEP RHEA Turkey Tech, Seta Medical, Netsafe Information System, and RML Lines.
15GF Score

Get the complete analysis for IST:ICUGS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺5.65
Price